Zidebactam restores sulbactam susceptibility against carbapenem-resistant Acinetobacter baumannii isolates is a research paper published in Frontiers in Cellular and Infection Microbiology (2022). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAID NIH HHS
Grant: R01 AI072219
NIAID NIH HHS
Grant: R15 AI047115
NIGMS NIH HHS
Grant: SC3 GM125556
NIAID NIH HHS
Grant: R01 AI063517
NIAID NIH HHS
Grant: R01 AI100560
National Institutes of Health
Grant: 5R01AI072219-12
Understanding B-Lactam Resistance in Acinetobacter baumannii
National Institutes of Health
Grant: 5R01AI063517-13
Challenges in beta-Lactamase Mediated Resistance
National Institutes of Health
Grant: 5I01BX001974-11
The Continuing Challenge of Carbapenemases in K. pneumoniae: KPC-2 & NDM-1
National Institutes of Health
Grant: 5SC3GM125556-03
Identifying host human products responsible for natural transformation of resistance traits in Acinetobacter baumannii
National Institutes of Health
Grant: 5R01AI100560-04
A Mechanism-Based Approach to Metallo-beta-Lactamase Inhibition
National Institutes of Health
Grant: 2R15AI047115-02A1
Dealing with Antibiotic Resistance: Antisense Technology
National Institutes of Health
FWCI
0.49
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals